ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

NSRX vs GRDX // 10Y YIELD & FRED MACRO BETA

Nasus Pharma Ltd. (NYSE) VS. GridAI Technologies Corp. (NASDAQ) • 15-METRIC TALLY: NSRX 3 — GRDX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NSRX VS. GRDX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC NSRX GRDX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — -30.00% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -20.00% -15.00 GRDX /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -13.20% -14.67% +1.47 NSRX /fcf-yield <GO>
Operating Margin -0.40% -60.00% +59.60 NSRX /operating-margins <GO>
Net Profit Margin -0.50% -60.00% +59.50 NSRX /net-margins <GO>
Revenue Growth (YoY) — — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 2/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 38.3 54.5 -16.27 GRDX /rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $37.4M $38.9M -$1.5M GRDX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR NSRX REV GRDX REV NSRX GROSS % GRDX GROSS % NSRX FCF GRDX FCF
FY 2025 $1.24B $36.3K — -50.0% -$4.9M -$5.7M
FY 2024 $0 $0 — — -$665.0K -$9.2M
FY 2023 $0 $0 — — -$1.0M -$12.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NSRX // BETA —
GRDX // BETA —